A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

NCT06975722 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: SAR442970
DRUG: Placebo

Sponsor

Sanofi